Navigating regulatory change in the US and Europe
Amid unpreceded regulatory disruption, and landmark legislative change, biopharma manufacturers are being subjected to an onslaught of new directions with which to contend. This session will focus on some of the key challenges facing biopharma manufacturers as they strive to remain responsive to regulatory changes, including:
Clifford Rossi
Dr. Rossi is Professor-of-the-Practice, an Executive-in-Residence, and Director of the Smith Enterprise Risk Consortium at the Robert H. Smith School of Business, University of Maryland. Prior to entering academia, Dr. Rossi had nearly 25 years of risk management experience in banking and government, having held senior executive roles at several of the largest financial services […]
Continuous Manufacturing:
Transforming Pharmaceutical Production for Efficiency and Agility
